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Deane, Fiocruz, Manaus, Brazil, 8 The Pathogen and Microbiome Institute, Northern Arizona University,
Flagstaff, Arizona, United States of America, 9 Núcleo de Medicina Tropical, Faculdade de Medicina,
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Histoplasmosis is acquired by inhalation of spores of the dimorphic fungus Histoplasma
spp. Although this pathogen is distributed worldwide, it is more prevalent in the Americas.
However, the real burden of histoplasmosis remains undefined in many endemic regions.
Methodology
We conducted a series of 61 autopsies to individuals who died in a hospital in the Brazilian
Amazon focused on infectious diseases. We performed a detailed histological and microbio-
logical evaluation with genetic characterization of Histoplasma strains with the aim to evalu-
ate the contribution of histoplasmosis to morbidity and mortality. Additionally, we assessed
the clinicopathological correlation.
Principal findings
Evidence of Histoplasma infection was detected in 21 patients (34%). Eight cases were dis-
seminated infections, all of them occurred in HIV-positive patients. Six cases were localized
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histoplasmosis, limited to the lungs. In seven patients Histoplasma DNA was detected by
PCR in patients with no histological lesions. Histoplasma infection was detected in 38%
of HIV-positive patients and was a major contributor to death in 22% of them. Lungs,
liver and spleen were affected in all cases of disseminated histoplasmosis. Phylogenetic
analysis of the strains suggested a high diversity of Histoplasma species circulating in
the Brazilian Amazon. Histoplasmosis was clinically missed in 75% of the disseminated
infections.
Conclusions
The high incidence of histoplasmosis, the low index of clinical suspicion, and the severity of
the disseminated disease highlight the need of proactively implementing sensitive routine
screening methods for this pathogen in endemic areas. Antifungal prophylaxis against His-
toplasma should be encouraged in the severely immunocompromised HIV patients in these
areas. In conclusion, substantial mortality is associated with disseminated histoplasmosis
among HIV-positive patients in the Brazilian Amazon.
Author summary
Histoplasmosis is a fungal infection caused by inhalation of spores of the fungus Histo-
plasma spp. It occurs in specific endemic areas, such as areas of USA, Africa and Latin
America. However, the real burden of histoplasmosis remains unknown in many endemic
regions. Clinically, histoplasmosis is frequently misdiagnosed as tuberculosis. The current
study was carried out to explore the frequency and characteristics ofHistoplasma infection
in a series of autopsies conducted in the Brazilian Amazon. We found evidence of Histo-
plasma infection in one-third of the deceased patients. A significant proportion of the
cases were disseminated infections, with extensive involvement and severe damage of
most organs. All these disseminated infections occurred in HIV-positive patients. Strik-
ingly, histoplasmosis was clinically missed in more than two-thirds of these patients and
had an extremely high mortality. In conclusion, the high frequency and mortality of histo-
plasmosis, together with the frequent misdiagnosis of the disease, highlight the need of
implementation of sensitive screening methods for Histoplasma in HIV patients in
endemic areas. Additionally, antifungal prophylaxis against Histoplasma should be
encouraged in the severely immunocompromised HIV patients in these areas.
Introduction
Histoplasmosis is a fungal infection acquired by inhalation of microscopic spores of the dimor-
phic fungus Histoplasma spp. Although this pathogen has a worldwide distribution, histoplas-
mosis is more prevalent in the Americas [1–4]. In Brazil, histoplasmosis is highly endemic in
the Northern regions, particularly in the Amazon, as well as in Mid-Western and South-East-
ern areas [4, 5].
Two distinct varieties Histoplasma are recognized: H. capsulatum variety capsulatum,
responsible for American histoplasmosis, and H. capsulatum variety duboisii, causing African
histoplasmosis [3]. Recent genetic analyses have refined the previous taxonomic categorization
of the capsulatum variety: H.mississippiensis (NAm1) and H. ohiensis (NAm2) are endemic to
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North America while H. capsulatum (Panama), H. suramericanum (LAmA) and other genetic
clusters such as LAmB, Northeast BR1 and Northeast BR2 are endemic to Latin America and
frequently detected in people living with HIV [6].
H. capsulatum infections in immunocompetent individuals are typically asymptomatic or
are associated with mild symptoms, but can cause severe disease in patients exposed to a large
inoculum of the fungus [7]. In contrast, immunocompromised patients, especially HIV-posi-
tive individuals, are much more likely to develop a disseminated infection [8]. In these
patients, disseminated histoplasmosis progresses rapidly and is always fatal if untreated [8].
Unfortunately, despite the scale-up of anti-retroviral therapy, disseminated histoplasmosis is
still an important cause of mortality in HIV-positive people living in endemic areas [9]. In
Latin America, recent estimations suggest that the incidence and mortality of histoplasmosis
in HIV-positive patients may be even higher than those of tuberculosis [10, 11]. However, the
real burden of histoplasmosis and its associated mortality in many endemic regions, including
Brazil, is poorly known [11, 12].
Most of the clinicopathological data on histoplasmosis is based on case series [13–16] and
individual case reports, mostly in HIV-positive patients [17]. The majority of these reports
show that lungs, spleen, liver and bone marrow are the most frequently affected organs. How-
ever, any tissue can be involved, including central nervous system, adrenal glands, gastrointes-
tinal tract and lymph nodes [18–20]. Clinically, histoplasmosis is frequently missed, partly due
to the overlap of its symptoms with those of tuberculosis [1]. However, autopsy studies of fatal
histoplasmosis focusing on the clinicopathological correlation are very scarce [17–19, 21, 22].
In this study, we explored the prevalence and mortality associated with histoplasmosis in a
series of 61 complete autopsies conducted in a referral hospital located in the Brazilian Ama-
zon [23]. We analyzed the clinical signs and symptoms, the treatments received, and the histo-
pathological and microbiological findings of all cases of histoplasmosis.
Methods
Ethics statement
The study received the approval of the Clinical Research Ethics Committee of the Hospital
Clinic of Barcelona (File 2013/8677) and the local (Manaus, Amazonas state) and National
(Brazil) Bioethics Committees (CAAE 28905514.0.0000.0005/2014). Written informal consent
was obtained from the relatives of the deceased individuals.
Study setting
This study was part of an observational study conducted at the Fundação de Medicina Tropical
Dr.Heitor Vieira Dourado [23], a tertiary referral hospital specialized in the diagnosis and
treatment of tropical diseases. The hospital is located in the municipality of Manaus (North
East of the Amazonian State). The city population is of 2,094,301 inhabitants, the majority
residing in urban and peri-urban areas [24].
Patients included in the study
We included in this study patients who died at the Fundação de Medicina Tropical Dr. Heitor
Vieira Dourado from March 2014 to February 2015 and fulfilled the following inclusion crite-
ria: (1) a complete autopsy requested by the clinician as part of the medical evaluation of the
patient, (2) written informed consent to perform the autopsy given by the relatives and (3) a
post-mortem interval time of less than 48 hours.
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Autopsy procedures
Complete postmortem procedure was conducted by a study pathologist with the assistance of
a trained pathology technician. Before the procedure, the pathologist thoroughly revised the
clinical records of the deceased patient. The autopsy procedures and detailed pathological
methods used have been reported elsewhere [25–27]. In brief, the protocol started with the
external examination of the body, followed by disinfection of its surface and collection of 20
mL of blood and cerebrospinal fluid for microbiological testing. Afterwards, all the thoraco-
abdominal organs, as well as the central nervous system were eviscerated and dissected for
detailed gross examination. Then, samples from lungs, liver, spleen, central nervous system
and bone marrow were obtained for microbiology and samples of these organs as well as heart,
kidneys, stomach, bowel, pancreas, adrenal glands, bladder, lymph nodes, skin, and of uterus
in all women of reproductive age, were obtained for pathological evaluation. In addition, any
other grossly identified lesion was collected for histological and microbiological analysis. His-
tological samples were fixed in formalin. Microbiological tissue samples were collected into
tubes filled with lysis buffer (ATL buffer, Qiagen, Hilden, Germany).
Microbiological and pathological methods and cause of death attribution
The general microbiological [25–27] and pathological methods [25, 26] have been reported
elsewhere. The study comprised in all cases detection of antibodies against HIV-1/2, polymer-
ase chain reaction (PCR) analyses for respiratory viruses and bacteria, bacterial/fungal culture
of blood, cerebrospinal fluid, liver, lungs, and central nervous system. In patients confirmed to
be HIV-positive, viral load testing and an additional microbiological screening for common
opportunistic pathogens was conducted. Other microorganisms were further explored
depending on the specific pathological findings observed.
The histological evaluation included hematoxylin and eosin stain in all samples and histo-
chemical and/or immunohistochemical stains whenever required to reach a cause of death
diagnosis.
Once all the analyses of the autopsy samples were completed, a panel composed of a pathol-
ogist, a microbiologist, and a clinician with expertise in infectious diseases evaluated all the
data of the complete autopsy and the clinical records, and assigned the main diagnosis of cause
of death and contributing to death conditions. All conditions involved in the chain of events
leading to death were coded following the International Classification of Diseases, tenth revi-
sion (ICD-10) [28]. Fundamental diseases contributing to the death were classified as underly-
ing conditions (e.g. HIV infection). The immediate cause of death and not the underlying
disease was considered as the main cause of death diagnosis (e.g. disseminated histoplasmosis
in an HIV-positive patient). In all cases, the assignment was made after discussion of the com-
plete information (clinical data, images, pathology and microbiology results). In case of dis-
agreement, three independent experts (N.R., M.J.M., J.C.H) reviewed all the data including the
histological slides and provided a final diagnosis.
Identification and characterization of Histoplasma infections
The presence ofHistoplasma was screened in all 61 cases in both lungs. The screening was con-
ducted using both histological methods (Grocott-Gomori silver stain [GMS]) and a real-time
PCR. Two different real-time PCR methods were used, a SYBR green-based method with melt-
ing curve analysis and a Taqman based assay [29, 30]. In all cases with evidence of Histoplasma
infection in lungs (either by the observation of the fungi in the histological evaluation or by a
positive PCR), the liver, spleen, bone marrow, and central nervous system were tested by both
GMS stain and PCR. The samples of heart, kidney, adrenal gland, lymph node, bowel,
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pancreas, uterus and skin were analyzed only with GMS. Finally, blood and cerebrospinal fluid
were tested by PCR.
Histoplasma molecular typing was performed by PCR amplification and Sanger sequencing
of the tub, arf and h-anti genes following a previously published Multilocus Sequencing Typing
protocol [31]. A DNA matrix of over 250 sequences comprising the current known Histo-
plasma diversity was used for the molecular systematics studies [6]. The sequences from the
current study were added to the dataset, aligned using the ClustalW matrix and finally manu-
ally inspected in the BioEdit software [32]. Maximum likelihood phylogenetic analysis was per-
formed using the IQTREE software [33], and the best nucleotide substitution model was
calculated using the–m MPF (ModelFinder) function [34]. One thousand ultrafast bootstraps
and SH-like approximate likelihood ratio test were used to calculate the branch support [35].
Finally, we visualized the best Maximum likelihood tree topology using the FigTree software
[36] and compared the strains identified in the study with other well-characterized Histo-
plasma species and lineages.
Classification of Histoplasma infections
Three categories of Histoplasma infection were defined. Disseminated histoplasmosis was
defined by the histological and microbiological evidence of Histoplasma in more than one
organ or fluid. Localized pulmonary histoplasmosis was diagnosed in cases with Histoplasma
infection detected by microbiological and histological methods, limited to the lungs. Finally,
HistoplasmaDNA detection was defined as the detection of Histoplasma by molecular tests in
absence of histological lesions or visible fungi in the GMS stain. The inclusion of a case in this
latter category required: i) a positive result by the two PCR methods, or ii) a positive result




During the study period, 176 deaths occurred at the hospital. An autopsy was performed
approximately to one-third of the deceased patients, a percentage slightly higher than the per-
centage of autopsies routinely performed at the institution (18%). In the overall group of the
deceased patients 65% were HIV-positive, median age was 36.3 years (range 13.9 to 82.5
years), and 126 (71%) were males.
The study included 61 patients. Fifty-nine patients were adults (two of them were maternal
deaths), and two patients were children (both 13 years-old). The median age of the study
group was 34.8 years (range 13.9 to 81.5 years) and 39 (64%) were males.
Detection of Histoplasma
Evidence ofHistoplasma infection was identified in 21/61 cases (34%). Disseminated histoplas-
mosis was diagnosed in eight cases (13%). In six of these patients (6/61, 10%) was the final
cause of death. In the remaining two cases (3%), histoplasmosis was considered as a condition
significantly contributing to death, but in association with another opportunistic infection
(cryptococcal meningitis in one case and Pneumocystis jirovecii pneumonia in the second
case).
Six patients (10%) had localized pulmonary histoplasmosis and seven (11%) showed Histo-
plasmaDNA detection restricted to the lungs.
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Association with HIV
Thirty-seven out of the 61 (61%) patients included in the study tested positive for HIV. Four-
teen out of the 21 patients with Histoplasma infection (67%) were HIV-positive, including all
the eight patients with disseminated histoplasmosis, 4/6 with localized pulmonary histoplas-
mosis and 2/7 with Histoplasma DNA detection. Remarkably, 14 out of 37 HIV-positive
patients (38%) had Histoplasma infection. Histoplasma was the main cause of death in 16% (6/
37), and significantly contributed to death in 22% (8/37) of HIV-positive patients.
Clinical characteristics of the patients with disseminated histoplasmosis
The demographic characteristics, HIV status, HIV viral load, pre-mortem CD4 cell counts,
antiretroviral and antifungal treatment, clinical signs and symptoms, and the final cause of
death of the eight disseminated histoplasmosis are summarized in Table 1. The median age of
these patients was 39.8 years (range 27–78 years) and 7/8 cases were males. Only three patients
were receiving antiretroviral therapy. The HIV infection was suspected in all eight cases during
hospitalization, but could be confirmed during life only in six patients. The last CD4 count
Table 1. Demographical, clinical characteristics and antifungal treatment of the eight patients with disseminated histoplasmosis.






















423 48 M + 4,390 110 Yes
2 months

















428 27 M + 27 16 Yes
1 month








































456 39 M + 66,600 42 No Fluconazole Fever, cough, dyspnea,
diarrhea, headache,







NA: not available; M: male; F: female; NA: not available data
� This patient received prophylaxis with fluconazole prior to hospital admission.
https://doi.org/10.1371/journal.pntd.0009286.t001
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was available in six cases, with a median count of 52 cells/mL (range 16–110 cells/mL). Diar-
rhea was the most common symptom (six patients), followed by abdominal pain, weight loss,
and dyspnea (three cases each), and fever, cough, and headache (two cases each). Upon admis-
sion to hospital, two patients were lethargic, and one showed decreased level of consciousness
with focal neurological deficits. Chest radiograph was conducted in seven cases, and showed
radiological lesions in five cases (reticular or interstitial pattern in three cases and consolida-
tion in two cases). The liver transaminase levels were elevated in six patients.
Histoplasmosis was included in the clinical differential diagnosis in two cases but was con-
sidered as the cause of death by the clinicians in only one case. In six patients, Histoplasmosis
had not been clinically suspected; four of these cases were clinically suspicious of tuberculosis.
By protocol, all eight patients received antifungal treatment during hospitalization. Six patients
were treated only with fluconazole, one received both fluconazole and Amphotericin B, and
one received only Amphotericin B (Table 1). A single patient received antifungal prophylaxis
prior to admission to hospital (only fluconazole). All patients with disseminated histoplasmo-
sis had other typical HIV-related opportunistic co-infections (cytomegalovirus in seven cases,
toxoplasmosis in six cases, candidiasis in four cases, pneumocystosis in two cases, and tubercu-
losis and cryptococcosis in one case each). Most of these opportunistic co-infections were
mainly diagnosed based on molecular analysis and did not have any associated histological
lesions.
The mean time between admission to death was 12 days (range 0.5–50.9 days). Two patients
died in the first day of admission.
Pathological and microbiological findings of the disseminated
histoplasmosis
Table 2 shows the results of the real-time PCR for Histoplasma and the GMS staining in dis-
seminated histoplasmosis. Both lungs, the liver, and spleen were involved in all the eight
patients. The following most affected organs were bone marrow (seven cases), central nervous
system, heart, kidney, and adrenal gland (four cases each), bowel and lymph node (three cases
each), and skin, pancreas and bladder (two cases each).
Histologically, pulmonary lesions were ill-defined, granulomatous nodules with caseous-
like necrosis, resembling typical tuberculous lesions. The lesions in other organs were more
heterogeneous, including suppurative granulocytic infiltrates, disperse fungi-laden

































423 30.1 / + 33.7 / + 29.0 / + - / + 34.0 / + 38.3 / + + - + + - - - -
425 20.2 / + 19.8 / + 21.9 / + 19.9 / + NA / + 27.0 / + + + + NA + + 30.1 29.1
428 26.4 / + 25.9 / + 23.2 / + 25.5 / + 24.0 / + 28.8 / + + + + NA - + 32.2 35.4
457 23.7 /+ 25.0 / + 22.4 / + 20.8 / + 21.8 / + 29.3 / + + + + + + - 27.0 28.9
442 30.2 / + 32.8 / + 36.8 / + 36.4 / + 32.7 / - - / - - - - + - - 35.6 -
452 36.4 / + 35.7 / + 38.1 / + 35.3 / + 31.1 / - - / - - - - - + - - -
460 36.7 / + 37.2 / + - / + 36.5 / + - / - - / - - + - - - - - -
456 36.7 / + 37.2 / - 38.0 / + 36.5 / - - / + - / - - - - - - - - -
Cycle threshold (Ct) values of the Histoplasma real-time PCR assay are indicated in positive samples. Samples in which histoplasma DNA was not detected are shown as
-; CNS: central nervous system; CSF: cerebrospinal fluid; NA: not available
https://doi.org/10.1371/journal.pntd.0009286.t002
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macrophages, and accumulations of visible yeast cells without presence of macrophages or any
other inflammatory infiltrates. The central nervous system involvement byHistoplasma was
very focal in the four cases and predominantly vascular, with no granulomatous reaction.
Representative images of the lung lesions and the extrapulmonary involvement are shown
in Figs 1 and 2, respectively. In three patients, the fungi were identified histologically and/or
microbiologically in more than ten different samples.
Molecular typing of Histoplasma strains
In four patients who died of disseminated histoplasmosis, molecular typing of Histoplasma
was successfully achieved from DNA extracted from lung (two cases), spleen (one case) and
liver (one case). Phylogenetic analysis of the sequenced strains of Histoplasma suggested that
those belong to three different previously identified lineages as shown in Fig 3. Two strains
were closely related with the Panama group whereas one strain grouped with the recently
Fig 1. Autopsy findings in the lungs of patients with disseminated histoplasmosis. (A) Formalin-fixed lung specimen showing countless yellowish nodular lesions.
(B) Lung alveoli with two ill-defined granulomatous nodules with peripheric inflammatory infiltrate simulating tuberculous lesions (hematoxylin & eosin 200x). (C)
Higher magnification of lung lesions shows granulomatous infiltrate with caseous-like necrosis; fungi are visible in the cytoplasm of the macrophages (hematoxylin &
eosin 400x). (D) Grocott-Gomori stain highlights small-size yeast cells, morphologically characteristic of Histoplasma capsulatum (Grocott-Gomori stain 600x).
https://doi.org/10.1371/journal.pntd.0009286.g001
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described Northeastern Brazil (BR1) clade [6] and one strain represented a yet Unknown I
clade which contains other strains from Latin America.
Characteristics of the patients with localized pulmonary histoplasmosis
and those with Histoplasma DNA detection
Table 3 shows the main findings in six patients with localized pulmonary histoplasmosis and
in seven patients with HistoplasmaDNA detection in lungs, including the demographic
Fig 2. The autopsy findings in extrapulmonary organs in disseminated histoplasmosis. (A) Massive enlargement of mesenteric lymph nodes.
No intestinal involvement byHistoplasma was observed in this case. (B) The microscopic liver lesions byHistoplasma: granule-laden macrophages
in sinusoids and ill-defined granulomatous lesions (hematoxylin & eosin 400x). (C) Budding oval-shaped, mostly arranged in a grape cluster,
Histoplasma yeasts positive for Grocott-Gomori stain (600x). (D) Pancreatic parenchyma showing easily identifiable, abundant fungal spores
affecting acini and islet of Langerhans (hematoxylin & eosin 400x). (E) Large bowel wall with extensive submucosal involvement by visible fungal
spores (hematoxylin & eosin 400x), highlighted with Grocott-Gomori stain (400x)(F). (G) and (H), Adrenal gland and lymph node, respectively,
with the presence of dot-like, bluish structures, consistent withHistoplasma (hematoxylin & eosin 400x). (I) Isolated, paired and clustered budding
ofH. capsulatum yeasts stained positive with Grocott-Gomori stain (600x).
https://doi.org/10.1371/journal.pntd.0009286.g002
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characteristics, HIV status and viral load, pre-mortem CD4 count, antiretroviral and antifun-
gal treatment received, as well as the final cause of death and the results of Histoplasma testing
in lung samples. No evidence of Histoplasma was found in any other organ. In all the 13 cases,
another disease was identified as the main cause of death. The six HIV-positive patients in this
group died of an AIDS-associated infection. One HIV-negative individual with Histoplasma
DNA detection was immunosuppressed due to corticosteroid treatment and received Ampho-
tericin B due to a clinical diagnosis of oral histoplasmosis.
Discussion
In this series of 61 complete autopsies conducted in the Brazilian Amazon, histoplasmosis was
the main cause of death in 10% of the patients. In addition, Histoplasma significantly contrib-
uted to death in 3% of the patients, caused pulmonary disease in 10% and was detected by
molecular methods in 11% of the individuals included in this series. Although the number of
conducted autopsies was relatively low, the overall prevalence and mortality (34% and 13%,
respectively) of Histoplasma infection found in our study were remarkably high. Among HIV-
positive patients, the prevalence and mortality were even higher (38% and 22%, respectively).
Fig 3. Unrooted maximum likelihood tree of 255 Histoplasma sp. taxa. Branch lengths are proportional to the number of nucleotide substitutions
accumulated by every lineage (see the scale below the tree). The four genotyped strains (1 to 4) are highlighted in red and the main genetic clusters of the
genus Histoplasma are shown. Nam2: North American class 2, Lam A2, LAmA1, Lam B: Latin American group A and group B, BAC: bat-associated
cluster (BAC), BR: Brazil.
https://doi.org/10.1371/journal.pntd.0009286.g003
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Another autopsy study conducted in Brazil reported even higher prevalence and mortality of
histoplasmosis among HIV positive patients (55% and 45%, respectively) who died in the
period 2005–2018 [16]. Contrarily, an autopsy-based study conducted among HIV-positive
individuals between 1996–2003 in our institution found thatHistoplasma caused 13% of
deaths [37]. The higher frequency in our study might be partially explained by the thorough
molecular and histological screening for Histoplasma. The low levels of CD4 cells and the high
HIV-1 viral load observed in our cases, and in other autopsy cohort [16] highlight the elevated
fatality rate of histoplasmosis in patients with advanced HIV disease in the endemic areas in
Brazil. The advanced stages of HIV disease are likely the consequence of the lack of antiretrovi-
ral treatment in these patients [16, 38]. These data are striking, as this therapy is freely and
widely available to all HIV positive individuals since 1997. An acceleration of anti-retroviral
roll-out is thus an urgent action that would probably reduce mortality associated with histo-
plasmosis and with other AIDS-associated infections.
Table 3. Demographical, clinical characteristics, prophylactic treatment, results of the real-time PCR for Histoplasma and the Grocott-Gomori metenamine silver
(GMS) stain in the lungs of patients with localized pulmonary histoplasmosis (LPH) and patients with Histoplasma DNA detection (HDD) in the lungs without his-
tological lesions.






























459 30 M LPH 36.8 /
+
- / + + 737 6 No Fluconazole HIV Disseminated
cytomegalovirus
None




+ 38,250 20 Yes Fluconazole HIV Miliary tuberculosis None




+ 1110 187 NA - HIV Cerebral
toxoplasmosis
Hypertension
427 22 F LPH 37.1 /
+
- / - + 540,000 NA No Fluconazole HIV Disseminated
cytomegalovirus
P.jirovecii, T.gondii
414 72 F LPH 36.2 /
+
- / + - NT NA NA - Cirrhosis Pneumonia (no
agent).
Panhypopituitarism





461 50 M HDD 37.8 / - 36.6 /
-
+ 226 11 Yes - HIV Cytomegalovirus
pneumonia
K. pneumoniae
406 29 M HDD - / - 37.8 /
-
+ 28,600 NA No Fluconazole HIV Miliary tuberculosis T.gondii
429 39 M HDD 37.3 / - 37.2 /
-





450 47 M HDD 36.2 / - 36.9 /
-
- NT NA NA - HTLV 1–2 Meningitis (Neisseria
meningitidis).
S.pneumoniae
443 81 F HDD 36.7 / - 36.0 /
-
- NT NA NA - None Disseminated gastric
adenocarcinoma
None
405 38 M HDD - / - 35.0 /
-
- NT NA NA - None Sepsis (Neisseria
meningitidis)
Adenovirus






HBV: hepatitis B virus; HDV: hepatitis D virus; HTLV: human T-lymphotrophic virus; M: male; F: female; NA: not available; NT: not tested due to insufficient amount
of sample.
https://doi.org/10.1371/journal.pntd.0009286.t003
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Histoplasmosis is considered a neglected disease and, although it is known to be an impor-
tant contributor to HIV-related mortality in endemic areas of Latin America, many cases are
clinically missed. In our study, histoplasmosis was suspected only in two out of eight patients
with disseminated disease. Similar rates of underdiagnosis were reported in Brazilian autopsy
cohort [16]. The non-specific clinical presentation of the disease and the fact that the microbi-
ological diagnosis remains challenging in resource-limited areas make this infection markedly
underdiagnosed [39, 40]. The definitive diagnosis of histoplasmosis has traditionally relied on
culture or direct examination of clinical specimens with special stains [41]. However, these
procedures are time-consuming and have low sensitivity. Molecular techniques based on PCR
offer higher sensitivity [1] but are not yet fully standardized and are not routinely available in
many countries where the disease is prevalent. Histological examination is particularly useful
for the diagnosis of histoplasmosis [41]. However, the identification of the fungus in tissues
with H&E may be challenging, especially when present in small numbers. Special stains such
as GMS are particularly helpful in these cases [21], as shown in our study. Damasceno-Escoura
et al [16] reported even higher diagnostic rates of disease establishing the diagnosis exclusively
on histology. In recent years, novel diagnostic approaches including rapid tests have been
developed [42]. Antigen detection assays in urine samples are relatively easy to perform and
offer good sensitivity and specificity but still remain unavailable in most laboratories in
endemic areas. Of note, newly developed ELISA tests for the detection of Histoplasma antigens
represent a promising tool to expand the microbiological diagnosis of the disease in areas
where it is mostly needed [43, 44].
The evolution of disseminated histoplasmosis is rapid and always fatal if untreated [8]. In
addition to laboratory diagnostics, access to adequate treatment, which includes liposomal
Amphotericin B followed by oral itraconazole for up to one year is also urgently required. Itra-
conazole is also recommended as prophylaxis in immunosuppressed patients [21]. In line with
the high underdiagnosis rates, prophylactic or treatment strategies for histoplasmosis were
clearly suboptimal in our series, simillarly to the results of a recent Brazilian series [16]. A spec-
trum of Histoplasma infections was observed in our study. Some patients hadHistoplasma
DNA detection in lungs in the absence of identifiable yeasts, while other cases showed local-
ized pulmonary histoplasmosis with clearly identifiable yeasts in the lungs associated to mild
histological lesions. The patients with only molecular evidence of Histoplasma likely represent
initial stages of the infection in which histological lesions are either not yet developed or are
restricted to lung areas that were not sampled for histological analysis. Finally, some patients
had severe disseminated infections involving multiple organs, such as the lungs, spleen, and
liver, in agreement with cases reported in other series [14, 15, 44]. Curiously, a recent study in
a different area of Brazil [16] showed thatHistoplasma was more frequently identified in the
lymph nodes and less commonly involved the liver and the spleen compared with our series.
Interestingly, although only four strains could be subjected to molecular typing, we identi-
fied three different Histoplasma genotypes, consistent with a high diversity of this fungus cir-
culating in the area of study, in line with previous reports from Latin America [45]. Two of
these clades have been recently described in molecular epidemiology studies in Northeast Bra-
zil and Colombia/Panama [46]. In our recent post-mortem study focused on cryptococcal dis-
ease-related mortality in Brazil and Mozambique, we also identified different molecular fungal
types within a small sample [47]. These data highlight the usefulness of molecular typing tech-
niques for a better characterization of fatal fungal infections.
One of the main strengths of the study is the use of the complete autopsy, the gold standard
for cause of death investigation. There are also significant limitations. Firstly, it was carried out
in a single tertiary hospital, specifically focused on infectious diseases. Consequently, there was
a high HIV prevalence among patients and thus, the cohort might not be representative of the
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overall population. This could limit the extrapolation of the results to other areas or health
facilities with less prevalence of HIV. Secondly, the number of severe histoplasmosis cases is
relatively small.
In conclusion, our study shows the high incidence and mortality associated with dissemi-
nated histoplasmosis among HIV-positive in the Brazilian Amazon. The low index of clinical
suspicion, and the severity of the disseminated disease warrant the need of implementation of
sensitive routine screening methods. Moreover, antifungal prophylaxis should be encouraged
in patients with advanced HIV disease living in hyper-endemic areas of histoplasmosis.
Finally, upscaling of antiretroviral therapy is needed as fatal histoplasmosis occurs among
patients with HIV with advanced disease who not receiving proper medical care.
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Writing – original draft: Natalia Rakislova, Juan Carlos Hurtado, Jaume Ordi, Miguel J.
Martı́nez.
Writing – review & editing: Natalia Rakislova, Juan Carlos Hurtado, Antonio E. M. Palhares,
Luiz Ferreira, Monique Freire, Marcus Lacerda, Wuelton Monteiro, Mireia Navarro, Isaac
Casas, Marcus de Melo Teixeira, Paola Castillo, Maria Teresa Rodrigo-Calvo, Lorena Mari-
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